US Stock MarketDetailed Quotes

AMPED AMPIO PHARMACEUTICALS INC

Watchlist

0.510
0.0000.00%

15min DelayTrading Nov 21 16:00 ET

7.69MMarket Cap-264P/E (TTM)

AMPIO PHARMACEUTICALS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-51.99%-5.94M

-155.46%-5.95M

-19.22%-4.94M

4.35%-14.09M

-28.61%-3.7M

-44.49%-3.91M

49.28%-2.33M

8.92%-4.15M

4.25%-14.73M

39.38%-2.88M

Net income from continuing operations

-76.66%-6.41M

41.77%-2.07M

-53.70%-5.64M

-7.43%-17.08M

-34.81%-6.22M

-7.78%-3.63M

-30.17%-3.56M

29.19%-3.67M

-16.61%-15.89M

-352.65%-4.62M

Operating gains losses

-425.68%-1.17M

-2,387.93%-2.89M

-781.46%-1.33M

-4,950.00%-3.49M

-525.35%-3M

-436.36%-222K

-188.55%-116K

81.83%-151K

101.48%72K

111.57%706K

Depreciation and amortization

31.94%347K

-6.57%256K

-10.88%262K

-7.05%1.09M

-9.93%263K

-10.54%263K

-7.43%274K

-0.34%294K

-7.47%1.18M

-1.68%292K

Other non cash items

----

-87.18%80K

--0

0.00%80K

680.00%624K

--0

Change In working capital

-119.78%-811K

-215.87%-1.16M

220.25%1.05M

229.97%2.58M

1,203.70%2.82M

-109.66%-369K

134.62%1M

-200.00%-869K

-246.06%-1.99M

-89.18%216K

-Change in prepaid assets

-25.00%381K

-22.32%-685K

202.92%670K

-203.85%-593K

-66.46%110K

7.63%508K

39.59%-560K

-193.27%-651K

144.93%571K

175.63%328K

-Change in payables and accrued expense

-36.69%-1.17M

-128.39%-450K

299.50%397K

231.80%3.26M

3,132.22%2.73M

-36.04%-853K

181.41%1.59M

-205.29%-199K

-191.67%-2.48M

-104.75%-90K

-Change in other current liabilities

-8.33%-26K

-13.04%-26K

-15.79%-22K

-9.88%-89K

-4.55%-23K

-14.29%-24K

-15.00%-23K

-5.56%-19K

-15.71%-81K

-22.22%-22K

Cash from discontinued investing activities

Operating cash flow

-51.99%-5.94M

-155.46%-5.95M

-19.22%-4.94M

4.35%-14.09M

-28.61%-3.7M

-44.49%-3.91M

49.28%-2.33M

8.92%-4.15M

4.25%-14.73M

39.38%-2.88M

Investing cash flow

Cash flow from continuing investing activities

-53.97%-97K

66.67%-16K

-81K

-186.36%-63K

-87.50%-15K

Net PPE purchase and sale

--0

-53.97%-97K

--0

66.67%-16K

--0

---81K

-186.36%-63K

-87.50%-15K

Cash from discontinued investing activities

Investing cash flow

--0

-53.97%-97K

--0

66.67%-16K

--0

---81K

-186.36%-63K

-87.50%-15K

Financing cash flow

Cash flow from continuing financing activities

-104.13%-111K

20.02%30.73M

88.22%20.48M

-93.19%495K

0.80%7.07M

516.06%2.69M

78.41%25.61M

235.08%10.88M

Net common stock issuance

--0

-102.80%-79K

25.33%32.83M

99.73%22.08M

-92.52%540K

2.16%7.39M

313.34%2.82M

115.71%26.19M

--11.06M

Proceeds from stock option exercised by employees

----

-70.11%234K

----

-79.79%783K

-90.92%320K

Net other financing activities

--0

75.94%-32K

-70.18%-2.33M

-270.91%-1.84M

85.62%-45K

0.00%-314K

45.93%-133K

17.79%-1.37M

-78.70%-495K

Cash from discontinued financing activities

Financing cash flow

--0

-104.13%-111K

20.02%30.73M

88.22%20.48M

-93.19%495K

0.80%7.07M

516.06%2.69M

78.41%25.61M

235.08%10.88M

Net cash flow

Beginning cash position

11.39%22.89M

82.47%28.84M

95.39%33.89M

165.55%17.35M

82.87%17.12M

324.39%20.55M

554.41%15.8M

165.55%17.35M

-13.88%6.53M

16.37%9.36M

Current changes in cash

-73.21%-5.94M

-225.33%-5.95M

-227.82%-5.06M

53.01%16.55M

110.07%16.77M

-175.92%-3.43M

95.51%4.75M

62.55%-1.54M

1,126.97%10.81M

628.11%7.99M

End cash Position

-1.00%16.95M

11.39%22.89M

82.47%28.84M

95.39%33.89M

82.87%17.12M

324.39%20.55M

554.41%15.8M

165.55%17.35M

Free cash flow

-51.38%-5.94M

-155.46%-5.95M

-16.93%-4.94M

4.10%-14.19M

-27.94%-3.7M

-42.56%-3.93M

49.28%-2.33M

7.14%-4.23M

3.98%-14.79M

39.17%-2.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-51.99%-5.94M	-155.46%-5.95M	-19.22%-4.94M	4.35%-14.09M	-28.61%-3.7M	-44.49%-3.91M	49.28%-2.33M	8.92%-4.15M	4.25%-14.73M	39.38%-2.88M
Net income from continuing operations	-76.66%-6.41M	41.77%-2.07M	-53.70%-5.64M	-7.43%-17.08M	-34.81%-6.22M	-7.78%-3.63M	-30.17%-3.56M	29.19%-3.67M	-16.61%-15.89M	-352.65%-4.62M
Operating gains losses	-425.68%-1.17M	-2,387.93%-2.89M	-781.46%-1.33M	-4,950.00%-3.49M	-525.35%-3M	-436.36%-222K	-188.55%-116K	81.83%-151K	101.48%72K	111.57%706K
Depreciation and amortization	31.94%347K	-6.57%256K	-10.88%262K	-7.05%1.09M	-9.93%263K	-10.54%263K	-7.43%274K	-0.34%294K	-7.47%1.18M	-1.68%292K
Other non cash items	----	----	----	-87.18%80K	--0	--0	--0	0.00%80K	680.00%624K	--0
Change In working capital	-119.78%-811K	-215.87%-1.16M	220.25%1.05M	229.97%2.58M	1,203.70%2.82M	-109.66%-369K	134.62%1M	-200.00%-869K	-246.06%-1.99M	-89.18%216K
-Change in prepaid assets	-25.00%381K	-22.32%-685K	202.92%670K	-203.85%-593K	-66.46%110K	7.63%508K	39.59%-560K	-193.27%-651K	144.93%571K	175.63%328K
-Change in payables and accrued expense	-36.69%-1.17M	-128.39%-450K	299.50%397K	231.80%3.26M	3,132.22%2.73M	-36.04%-853K	181.41%1.59M	-205.29%-199K	-191.67%-2.48M	-104.75%-90K
-Change in other current liabilities	-8.33%-26K	-13.04%-26K	-15.79%-22K	-9.88%-89K	-4.55%-23K	-14.29%-24K	-15.00%-23K	-5.56%-19K	-15.71%-81K	-22.22%-22K
Cash from discontinued investing activities
Operating cash flow	-51.99%-5.94M	-155.46%-5.95M	-19.22%-4.94M	4.35%-14.09M	-28.61%-3.7M	-44.49%-3.91M	49.28%-2.33M	8.92%-4.15M	4.25%-14.73M	39.38%-2.88M
Investing cash flow
Cash flow from continuing investing activities	0	0	0	-53.97%-97K	0	66.67%-16K	0	-81K	-186.36%-63K	-87.50%-15K
Net PPE purchase and sale	--0	--0	--0	-53.97%-97K	--0	66.67%-16K	--0	---81K	-186.36%-63K	-87.50%-15K
Cash from discontinued investing activities
Investing cash flow	--0	--0	--0	-53.97%-97K	--0	66.67%-16K	--0	---81K	-186.36%-63K	-87.50%-15K
Financing cash flow
Cash flow from continuing financing activities	0	0	-104.13%-111K	20.02%30.73M	88.22%20.48M	-93.19%495K	0.80%7.07M	516.06%2.69M	78.41%25.61M	235.08%10.88M
Net common stock issuance	--0	--0	-102.80%-79K	25.33%32.83M	99.73%22.08M	-92.52%540K	2.16%7.39M	313.34%2.82M	115.71%26.19M	--11.06M
Proceeds from stock option exercised by employees	----	----	----	-70.11%234K	----	----	----	----	-79.79%783K	-90.92%320K
Net other financing activities	--0	--0	75.94%-32K	-70.18%-2.33M	-270.91%-1.84M	85.62%-45K	0.00%-314K	45.93%-133K	17.79%-1.37M	-78.70%-495K
Cash from discontinued financing activities
Financing cash flow	--0	--0	-104.13%-111K	20.02%30.73M	88.22%20.48M	-93.19%495K	0.80%7.07M	516.06%2.69M	78.41%25.61M	235.08%10.88M
Net cash flow
Beginning cash position	11.39%22.89M	82.47%28.84M	95.39%33.89M	165.55%17.35M	82.87%17.12M	324.39%20.55M	554.41%15.8M	165.55%17.35M	-13.88%6.53M	16.37%9.36M
Current changes in cash	-73.21%-5.94M	-225.33%-5.95M	-227.82%-5.06M	53.01%16.55M	110.07%16.77M	-175.92%-3.43M	95.51%4.75M	62.55%-1.54M	1,126.97%10.81M	628.11%7.99M
End cash Position	-1.00%16.95M	11.39%22.89M	82.47%28.84M	95.39%33.89M	95.39%33.89M	82.87%17.12M	324.39%20.55M	554.41%15.8M	165.55%17.35M	165.55%17.35M
Free cash flow	-51.38%-5.94M	-155.46%-5.95M	-16.93%-4.94M	4.10%-14.19M	-27.94%-3.7M	-42.56%-3.93M	49.28%-2.33M	7.14%-4.23M	3.98%-14.79M	39.17%-2.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall